Since the overexpression of COX-2 in tumour may counteract the efficacy of cytotoxic chemotherapy due to the apoptosis resistance, the combination of chemotherapy with coxibs seems to be an attractive strategy to enhance the antitumour activity. The gene discussed is PTGS2; the disease is neoplasm.